Targeted therapies and emerging options for cardiomyopathies: florence advances in cardiomyopathy series

The rapid evolution of molecular cardiology, genetics, and targeted therapeutics is reshaping the management of cardiomyopathies and rare cardiovascular diseases. These conditions, though individually uncommon, collectively impose a significant global burden and often require highly specialized, multidisciplinary expertise. As scientific progress accelerates, there is a pressing need for a coordinated international forum where emerging therapeutic strategies can be critically examined, compared, and translated into meaningful clinical advances. To meet this need, the present workshop will welcome leading experts from around the world, for an interactive meeting dedicated to therapeutic innovation and the future of clinical trial design in this field.